| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Centessa Pharmaceuticals Plc (CNTA) has 12 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. CNTA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 360.3K | $14.31M | - | |
| CEO | 276.0K | $10.96M | - | |
| CEO | 243.3K | $9.66M | - | |
| Other | 105.4K | $4.19M | - | |
| Other | 89.9K | $3.57M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2021 | Medicxi Ventures Management (jersey) Ltd | 10% Owner | Buy | 600,000 | $20.00 | $12,000,000.00 | +18.6% | -12.2% | -87.1% | |
| Jun 2, 2021 | De Rubertis Francesco | Director | Buy | 600,000 | $20.00 | $12,000,000.00 | +18.6% | -12.2% | -87.1% |